GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Price-to-Free-Cash-Flow

Tissue Regenix Group (LSE:TRX) Price-to-Free-Cash-Flow : 342.50 (As of Jun. 05, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Price-to-Free-Cash-Flow?

As of today (2024-06-05), Tissue Regenix Group's share price is £0.685. Tissue Regenix Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00. Hence, Tissue Regenix Group's Price-to-Free-Cash-Flow Ratio for today is 342.50.

The historical rank and industry rank for Tissue Regenix Group's Price-to-Free-Cash-Flow or its related term are showing as below:

LSE:TRX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 255   Med: 307.5   Max: 357.5
Current: 345

During the past 13 years, Tissue Regenix Group's highest Price-to-Free-Cash-Flow Ratio was 357.50. The lowest was 255.00. And the median was 307.50.

LSE:TRX's Price-to-Free-Cash-Flow is ranked worse than
93.98% of 216 companies
in the Biotechnology industry
Industry Median: 30.345 vs LSE:TRX: 345.00

Tissue Regenix Group's Free Cash Flow per Share for the six months ended in Dec. 2023 was £0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was £0.00.

During the past 13 years, Tissue Regenix Group's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.50% per year. The lowest was -52.20% per year. And the median was -8.15% per year.


Tissue Regenix Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for Tissue Regenix Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Price-to-Free-Cash-Flow Chart

Tissue Regenix Group Annual Data
Trend Jan14 Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 260.00

Tissue Regenix Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 260.00

Competitive Comparison of Tissue Regenix Group's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Tissue Regenix Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tissue Regenix Group's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's Price-to-Free-Cash-Flow falls into.



Tissue Regenix Group Price-to-Free-Cash-Flow Calculation

Tissue Regenix Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.685/0.002
=342.50

Tissue Regenix Group's Share Price of today is £0.685.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tissue Regenix Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Tissue Regenix Group  (LSE:TRX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Tissue Regenix Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Tissue Regenix Group (LSE:TRX) Business Description

Traded in Other Exchanges
Address
Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.

Tissue Regenix Group (LSE:TRX) Headlines